Literature DB >> 400124

Long-term effects of pancreatic transplant function in patients with advanced juvenile-onset diabetes.

M L Gliedman, V A Tellis, R Soberman, H Rifkin, F J Veith.   

Abstract

Present methods of management of juvenile-onset diabetes mellitus do not prevent serious and debilitating complications affecting multiple organ systems. In an effort to reverse advanced forms of these complications, segmental transplantation of the pancreas has been performed on 10 patients, seven of whom simultaneously or subsequently received renal transplants. Long periods of normoglycemia (two to four and one-half years) were achieved in two patients who also maintained transplant kidney function. The course of these two patients is described to illustrate the possible value and limitations of the procedure. These patients had normal blood glucose levels, exhibited repeated normal intravenous glucose tolerance curves, and had repeated normal endogenous insulin levels. Their courses were characterized by (1) absence of problems related to pancreatic exocrine secretions into the bladder; (2) stable eye changes despite some episodes of hemorrhage from preexisting retinopathy; (3) vascular complications, including stroke and gangrene of extremities necessitating amputation despite successful femoropopliteal bypass grafting; (4) peripheral neuropathy; and (5) repeated infections. Both patients succumbed to vascular complications. Thus, pancreatic transplantation can maintain blood glucose and insulin at normal levels for extended periods of time. However, it does not reverse such complications as advanced retinopathy or atherosclerosis. Since the procedure may have value in preventing progression of these complications, it should be evaluated in patients with less advanced complications of diabetes.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 400124     DOI: 10.2337/diacare.1.1.1

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  10 in total

1.  The treatment of diabetic kidney disease.

Authors:  F C Goetz; C M Kjellstrand
Journal:  Diabetologia       Date:  1979-11       Impact factor: 10.122

Review 2.  Lessons learned from more than 1,000 pancreas transplants at a single institution.

Authors:  D E Sutherland; R W Gruessner; D L Dunn; A J Matas; A Humar; R Kandaswamy; S M Mauer; W R Kennedy; F C Goetz; R P Robertson; A C Gruessner; J S Najarian
Journal:  Ann Surg       Date:  2001-04       Impact factor: 12.969

3.  Pancreatic transplantation.

Authors: 
Journal:  Br Med J       Date:  1980-10-25

Review 4.  Pancreas and islet transplantation. II. Clinical trials.

Authors:  D E Sutherland
Journal:  Diabetologia       Date:  1981-04       Impact factor: 10.122

Review 5.  Pancreas and islet transplantation. I. Experimental studies.

Authors:  D E Sutherland
Journal:  Diabetologia       Date:  1981-03       Impact factor: 10.122

Review 6.  Pancreas and islet transplantation.

Authors:  J S Najarian; F C Goetz; D E Sutherland
Journal:  Jpn J Surg       Date:  1982

7.  Criteria for patient selection for pancreatic transplantation.

Authors:  L H Toledo-Pereyra
Journal:  Diabetologia       Date:  1982-04       Impact factor: 10.122

8.  One hundred pancreas transplants at a single institution.

Authors:  D E Sutherland; F C Goetz; J S Najarian
Journal:  Ann Surg       Date:  1984-10       Impact factor: 12.969

9.  Are the 'second generation' oral hypoglycemic agents really different?

Authors:  E F Pfeiffer
Journal:  Acta Diabetol Lat       Date:  1984 Jan-Mar

Review 10.  The natural history of diabetic nephropathy in type I diabetes and the role of metabolic control in its prevention, reversibility and clinical course.

Authors:  B L Wajchenberg; E Sabbaga; J A Fonseca
Journal:  Acta Diabetol Lat       Date:  1983 Jan-Mar
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.